{"id":297358,"date":"2026-10-09T10:45:25","date_gmt":"2026-10-09T05:15:25","guid":{"rendered":"https:\/\/univest.in\/blogs-2\/?p=297358"},"modified":"2026-10-09T10:45:25","modified_gmt":"2026-10-09T05:15:25","slug":"branded-and-generic-pharma-stocks-strong-roadmap","status":"publish","type":"post","link":"https:\/\/univest.in\/blogs-2\/branded-and-generic-pharma-stocks-strong-roadmap\/","title":{"rendered":"3 Branded and Generic Pharma Stocks With a Strong Future Roadmap: Mankind Pharma, Alkem Laboratories and Aurobindo Pharma"},"content":{"rendered":"

Mankind Pharma Rs 2,380.00, P\/E 47.91. Alkem Rs 5,249.50, P\/E 28.43. Aurobindo Pharma Rs 1,645.00, P\/E 25.46. Closing prices of 8 Oct 2026.<\/em><\/p>\n

\n

Quick Answer<\/strong><\/p>\n

Branded and generic pharma stocks with the clearest long-term roadmaps today include Mankind Pharma in branded formulations and consumer health, Alkem in domestic brands and generic exports and Aurobindo Pharma in generic formulations and ingredients. FY26 revenue growth was 14.8% at Mankind Pharma, 13.7% at Alkem and 5.6% at Aurobindo Pharma. P\/E stands at 47.91 for Mankind Pharma (industry 37.59), 28.43 for Alkem (industry 37.59) and 25.46 for Aurobindo Pharma (industry 37.59). Demand cycles, input costs and valuation decide how much of that growth the market keeps paying for, so each company’s risks need equal attention.<\/p>\n<\/p><\/div>\n

Branded and generic pharma stocks give investors exposure to drug makers that mix branded domestic sales with generic exports. Prescription growth, product mix and export approvals decide how steady earnings are.<\/p>\n

This list covers three branded and generic pharma stocks: Mankind Pharma for branded formulations and consumer health, Alkem Laboratories for domestic brands and generic exports and Aurobindo Pharma for generic formulations and ingredients. Every figure comes from the latest reported financials and the 8 October 2026 market close. Companies without complete current figures were left out.<\/p>\n

Click Here – Get Free Investment Predictions<\/strong><\/a><\/p>\n

\n
\n

Table of Contents<\/p>\nToggle<\/span><\/path><\/svg><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n